AGS-16M8F (AGS 16C3F / AGS-16C3F) Clinical Trials

TrialTitleStudy Record DetailPhaseSponsor/Collaborator
A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney CancerNCT01114230Phase IAstellas Pharma Inc / Agensys, Inc.
A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary HistologyNCT01672775Phase IAgensys, Inc / Astellas Pharma Inc
A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell CarcinomaNCT02639182Phase IAstellas Pharma Inc / Agensys, Inc.